Acutaas Chemicals Ltd
NSE:ACUTAAS

Watchlist Manager
Acutaas Chemicals Ltd Logo
Acutaas Chemicals Ltd
NSE:ACUTAAS
Watchlist
Price: 1 666.2 INR 0.92% Market Closed
Market Cap: 136.4B INR

Acutaas Chemicals Ltd
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acutaas Chemicals Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Acutaas Chemicals Ltd
NSE:ACUTAAS
Pre-Tax Income
₹2.2B
CAGR 3-Years
33%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Pre-Tax Income
₹75.3B
CAGR 3-Years
20%
CAGR 5-Years
30%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Pre-Tax Income
₹70.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Pre-Tax Income
₹140.7B
CAGR 3-Years
40%
CAGR 5-Years
53%
CAGR 10-Years
11%
Lupin Ltd
NSE:LUPIN
Pre-Tax Income
₹53.9B
CAGR 3-Years
164%
CAGR 5-Years
39%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Pre-Tax Income
₹28.8B
CAGR 3-Years
32%
CAGR 5-Years
16%
CAGR 10-Years
4%
No Stocks Found

Acutaas Chemicals Ltd
Glance View

Market Cap
136.4B INR
Industry
Pharmaceuticals

Acutaas Chemicals Ltd. engages in the development and commercialization of pharmaceutical intermediate products and specialty chemicals. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-09-14. The company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. The company manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The company has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

ACUTAAS Intrinsic Value
1 190.33 INR
Overvaluation 29%
Intrinsic Value
Price

See Also

What is Acutaas Chemicals Ltd's Pre-Tax Income?
Pre-Tax Income
2.2B INR

Based on the financial report for Mar 31, 2025, Acutaas Chemicals Ltd's Pre-Tax Income amounts to 2.2B INR.

What is Acutaas Chemicals Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
44%

Over the last year, the Pre-Tax Income growth was 164%. The average annual Pre-Tax Income growth rates for Acutaas Chemicals Ltd have been 33% over the past three years , 44% over the past five years .

Back to Top